Bristol-Myers Squibb (BMY) Falls Following Astra's Mystic Data; Merck (MRK) Gains
Tweet Send to a Friend
Bristol-Myers Squibb (NYSE: BMY) declined after AstraZeneca (NYSE: AZN) said its combination of Imfinzi and tremelimumab did ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
